Xinhua, a Chinese news channel, commented on the price cut on insulin which was brought on by China’s volume-based procurement (VBP) program....
CSL, the Australian giant, is in talks to buy Vifor Pharma in a deal that is valued at $7B, or A$10B. Vifor...
Sanofi will acquire Origimm Biotechnology as per an agreement signed by the two healthcare companies. The deal is expected to be finalized...
Aduhelm, Biogen’s new drug for Alzheimer’s disease, which was approved by FDA contentiously last month, continues to face criticism since then.
Two roxadustat partners AstraZeneca and FibroGen have received objections regarding safety concerns of their drug from the FDA after which the two companies
Israel Institute for Biological Research (IIBR), an institute run by Israel’s Defense Ministry, has signed a memorandum of understanding (MoU) with the NRx Pharmaceuticals
Pharma manufacturers lawsuits against payers and benefit managers preferred drugs are on FTC’s radar
The attention of federal antitrust regulators has been drawn to a slew of lawsuits filed by pharmaceutical companies, challenging the “preferred” medicine list of payers and benefit managers.
Acumen pharmaceuticals have demonstrated that it has a fundamental business insight to advance its Alzheimer’s drug product.
Many people find booking plane tickets, arranging road transportation and overnight lodging overwhelming. Add into that mix...
Xinhua, a Chinese news channel, commented on the price cut on insulin which was brought on by...
You might also likeRELATEDRecommended to you
Kintor pharmaceutical has signed an agreement to authorize Shanghai Fosun Pharmaceutical Development to commercialize its drug,
The launch of a new digital health innovation hub in Canada, Kaiser creating a digital formulary for mental health apps